KR840006438A - 혈전용해제 - Google Patents
혈전용해제 Download PDFInfo
- Publication number
- KR840006438A KR840006438A KR1019830002990A KR830002990A KR840006438A KR 840006438 A KR840006438 A KR 840006438A KR 1019830002990 A KR1019830002990 A KR 1019830002990A KR 830002990 A KR830002990 A KR 830002990A KR 840006438 A KR840006438 A KR 840006438A
- Authority
- KR
- South Korea
- Prior art keywords
- protease
- cellulose
- coagulated
- activity against
- arginine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 230000002537 thrombolytic effect Effects 0.000 title claims 2
- 239000003146 anticoagulant agent Substances 0.000 title 1
- 108091005804 Peptidases Proteins 0.000 claims description 41
- 239000004365 Protease Substances 0.000 claims description 41
- 102000035195 Peptidases Human genes 0.000 claims description 15
- 230000003480 fibrinolytic effect Effects 0.000 claims description 15
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 26
- 230000000694 effects Effects 0.000 claims 23
- 229920002678 cellulose Polymers 0.000 claims 22
- 239000001913 cellulose Substances 0.000 claims 22
- 230000002401 inhibitory effect Effects 0.000 claims 20
- 239000003112 inhibitor Substances 0.000 claims 18
- 239000000203 mixture Substances 0.000 claims 18
- 239000000126 substance Substances 0.000 claims 18
- 239000000243 solution Substances 0.000 claims 16
- 102000009123 Fibrin Human genes 0.000 claims 15
- 108010073385 Fibrin Proteins 0.000 claims 15
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 15
- 229950003499 fibrin Drugs 0.000 claims 15
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 12
- 238000010521 absorption reaction Methods 0.000 claims 12
- 239000000758 substrate Substances 0.000 claims 12
- 238000004090 dissolution Methods 0.000 claims 11
- 239000004480 active ingredient Substances 0.000 claims 10
- 238000000034 method Methods 0.000 claims 10
- 239000002244 precipitate Substances 0.000 claims 10
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 8
- 229940122618 Trypsin inhibitor Drugs 0.000 claims 8
- 101710162629 Trypsin inhibitor Proteins 0.000 claims 8
- 150000002500 ions Chemical class 0.000 claims 8
- 239000002753 trypsin inhibitor Substances 0.000 claims 8
- -1 N-benzoyl-L-tyrosine ester Chemical class 0.000 claims 7
- 239000002253 acid Substances 0.000 claims 7
- 239000004475 Arginine Substances 0.000 claims 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 6
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 6
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 6
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims 6
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 6
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims 6
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 6
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims 6
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 6
- 239000004472 Lysine Substances 0.000 claims 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 6
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims 6
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 6
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 6
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims 6
- 239000004473 Threonine Substances 0.000 claims 6
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 6
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims 6
- 238000000862 absorption spectrum Methods 0.000 claims 6
- 229960003767 alanine Drugs 0.000 claims 6
- 235000004279 alanine Nutrition 0.000 claims 6
- 229940024606 amino acid Drugs 0.000 claims 6
- 235000001014 amino acid Nutrition 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 6
- 235000003704 aspartic acid Nutrition 0.000 claims 6
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 6
- 229910052799 carbon Inorganic materials 0.000 claims 6
- 239000005018 casein Substances 0.000 claims 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims 6
- 235000021240 caseins Nutrition 0.000 claims 6
- DGTVXEHQMSJRPE-UHFFFAOYSA-M difluorophosphinate Chemical compound [O-]P(F)(F)=O DGTVXEHQMSJRPE-UHFFFAOYSA-M 0.000 claims 6
- 230000002255 enzymatic effect Effects 0.000 claims 6
- 238000010438 heat treatment Methods 0.000 claims 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 6
- 229960000310 isoleucine Drugs 0.000 claims 6
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims 6
- 229930182817 methionine Natural products 0.000 claims 6
- 229910052757 nitrogen Inorganic materials 0.000 claims 6
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 6
- 239000000843 powder Substances 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 239000011593 sulfur Substances 0.000 claims 6
- 229960004441 tyrosine Drugs 0.000 claims 6
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 6
- 239000004474 valine Substances 0.000 claims 6
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 claims 5
- 235000010469 Glycine max Nutrition 0.000 claims 5
- 244000068988 Glycine max Species 0.000 claims 5
- GHAZCVNUKKZTLG-UHFFFAOYSA-N N-ethyl-succinimide Natural products CCN1C(=O)CCC1=O GHAZCVNUKKZTLG-UHFFFAOYSA-N 0.000 claims 5
- HDFGOPSGAURCEO-UHFFFAOYSA-N N-ethylmaleimide Chemical compound CCN1C(=O)C=CC1=O HDFGOPSGAURCEO-UHFFFAOYSA-N 0.000 claims 5
- HFTGWHYUKOUNOV-ZKCHVHJHSA-N chembl1221905 Chemical compound NCC[C@H]1CC[C@H](C(O)=O)CC1 HFTGWHYUKOUNOV-ZKCHVHJHSA-N 0.000 claims 5
- 235000018417 cysteine Nutrition 0.000 claims 5
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims 5
- SRLROPAFMUDDRC-INIZCTEOSA-N ethyl N-benzoyl-L-tyrosinate Chemical compound C([C@@H](C(=O)OCC)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C=C1 SRLROPAFMUDDRC-INIZCTEOSA-N 0.000 claims 5
- 230000035945 sensitivity Effects 0.000 claims 5
- 108010039627 Aprotinin Proteins 0.000 claims 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 claims 4
- 241000361919 Metaphire sieboldi Species 0.000 claims 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 4
- FKMJXALNHKIDOD-LBPRGKRZSA-N TAMe Chemical compound NC(=N)NCCC[C@@H](C(=O)OC)NS(=O)(=O)C1=CC=C(C)C=C1 FKMJXALNHKIDOD-LBPRGKRZSA-N 0.000 claims 4
- 229960002684 aminocaproic acid Drugs 0.000 claims 4
- 238000005571 anion exchange chromatography Methods 0.000 claims 4
- GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 claims 4
- 108010052968 leupeptin Proteins 0.000 claims 4
- 229950000964 pepstatin Drugs 0.000 claims 4
- 108010091212 pepstatin Proteins 0.000 claims 4
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 claims 4
- 230000033885 plasminogen activation Effects 0.000 claims 4
- 239000003495 polar organic solvent Substances 0.000 claims 4
- 229940108519 trasylol Drugs 0.000 claims 4
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims 3
- 238000001042 affinity chromatography Methods 0.000 claims 3
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims 3
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims 3
- 235000011130 ammonium sulphate Nutrition 0.000 claims 3
- 238000005349 anion exchange Methods 0.000 claims 3
- 238000005194 fractionation Methods 0.000 claims 3
- HIVDOHPKFIBYPZ-VIFPVBQESA-N methyl (2s)-2-(benzylamino)propanoate Chemical compound COC(=O)[C@H](C)NCC1=CC=CC=C1 HIVDOHPKFIBYPZ-VIFPVBQESA-N 0.000 claims 3
- QRDFLIILGVFYCF-QMMMGPOBSA-N methyl (2s)-2-benzamidopropanoate Chemical compound COC(=O)[C@H](C)NC(=O)C1=CC=CC=C1 QRDFLIILGVFYCF-QMMMGPOBSA-N 0.000 claims 3
- 238000000926 separation method Methods 0.000 claims 3
- MRXDGVXSWIXTQL-HYHFHBMOSA-N (2s)-2-[[(1s)-1-(2-amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[(2s)-4-methyl-1-oxo-1-[[(2s)-1-oxo-3-phenylpropan-2-yl]amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid Chemical compound C([C@H](NC(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C=O)C1NC(N)=NCC1)C(O)=O)C1=CC=CC=C1 MRXDGVXSWIXTQL-HYHFHBMOSA-N 0.000 claims 2
- OLVPQBGMUGIKIW-UHFFFAOYSA-N Chymostatin Natural products C=1C=CC=CC=1CC(C=O)NC(=O)C(C(C)CC)NC(=O)C(C1NC(N)=NCC1)NC(=O)NC(C(O)=O)CC1=CC=CC=C1 OLVPQBGMUGIKIW-UHFFFAOYSA-N 0.000 claims 2
- 239000004471 Glycine Substances 0.000 claims 2
- 102000013566 Plasminogen Human genes 0.000 claims 2
- 108010051456 Plasminogen Proteins 0.000 claims 2
- MJOQJPYNENPSSS-XQHKEYJVSA-N [(3r,4s,5r,6s)-4,5,6-triacetyloxyoxan-3-yl] acetate Chemical compound CC(=O)O[C@@H]1CO[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O MJOQJPYNENPSSS-XQHKEYJVSA-N 0.000 claims 2
- 230000003213 activating effect Effects 0.000 claims 2
- 239000003463 adsorbent Substances 0.000 claims 2
- 108010086192 chymostatin Proteins 0.000 claims 2
- 238000005345 coagulation Methods 0.000 claims 2
- 230000015271 coagulation Effects 0.000 claims 2
- 239000000835 fiber Substances 0.000 claims 2
- 239000003527 fibrinolytic agent Substances 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- KFNRNFXZFIRNEO-NSHDSACASA-N (2s)-5-(diaminomethylideneamino)-2-[(4-methylphenyl)sulfonylamino]pentanoic acid Chemical compound CC1=CC=C(S(=O)(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C=C1 KFNRNFXZFIRNEO-NSHDSACASA-N 0.000 claims 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 claims 1
- 241001214176 Capros Species 0.000 claims 1
- 102000004190 Enzymes Human genes 0.000 claims 1
- 108090000790 Enzymes Proteins 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- 102000004142 Trypsin Human genes 0.000 claims 1
- 108090000631 Trypsin Proteins 0.000 claims 1
- 150000001450 anions Chemical class 0.000 claims 1
- 239000007853 buffer solution Substances 0.000 claims 1
- 238000010612 desalination reaction Methods 0.000 claims 1
- 238000011033 desalting Methods 0.000 claims 1
- 150000004985 diamines Chemical class 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000020764 fibrinolysis Effects 0.000 claims 1
- 238000002523 gelfiltration Methods 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- FORVAIDSGSLRPX-RGMNGODLSA-N methyl (2s)-2,6-diaminohexanoate;hydrochloride Chemical compound Cl.COC(=O)[C@@H](N)CCCCN FORVAIDSGSLRPX-RGMNGODLSA-N 0.000 claims 1
- 238000002156 mixing Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 claims 1
- 238000009938 salting Methods 0.000 claims 1
- 230000028327 secretion Effects 0.000 claims 1
- 239000012588 trypsin Substances 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP57173669A JPS5963184A (ja) | 1982-10-02 | 1982-10-02 | 新規なプロテア−ゼ |
| JP173669 | 1982-10-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR840006438A true KR840006438A (ko) | 1984-11-30 |
Family
ID=15964899
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019830002990A Ceased KR840006438A (ko) | 1982-10-02 | 1983-06-30 | 혈전용해제 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPS5963184A (enrdf_load_stackoverflow) |
| KR (1) | KR840006438A (enrdf_load_stackoverflow) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890004724A (ko) * | 1987-09-17 | 1989-05-09 | 히사시 미하라 | 신규 프로테아제 제제(製劑) |
| JP2006096673A (ja) * | 2004-09-28 | 2006-04-13 | Mihara Lr Kenkyusho:Kk | ミミズ製品の製造方法 |
-
1982
- 1982-10-02 JP JP57173669A patent/JPS5963184A/ja active Granted
-
1983
- 1983-06-30 KR KR1019830002990A patent/KR840006438A/ko not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5963184A (ja) | 1984-04-10 |
| JPH0429350B2 (enrdf_load_stackoverflow) | 1992-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kagan et al. | Purification and properties of four species of lysyl oxidase from bovine aorta | |
| AU643835B2 (en) | Proteases causing abnormal degradation of amyloid beta-protein precursor | |
| TAKAHARA et al. | Purification and characterization of peptidylarginine deiminase from rabbit skeletal muscle | |
| Kaminogawa et al. | Isolation and characterization of a prolidase from Streptococcus cremoris H61 | |
| Kohno et al. | Immunoaffinity purification and characterization of leucine aminopeptidase from human liver. | |
| Tachi et al. | An X-prolyl dipeptidyl-aminopeptidase from Aspergillus oryzae | |
| Barrabin et al. | Isolation and characterization of gyroxin from Crotalus durissus terrificus venom | |
| CA2777650C (en) | Electrophoretic analysis method | |
| ES2224109T3 (es) | Procedimiento de preparacion de proteina c humana activada. | |
| KR840006438A (ko) | 혈전용해제 | |
| de Lumen et al. | α-N-Benzoylarginine-β-naphthylamide Amidohydrolase of Rat Liver Lysosomes | |
| Swanson et al. | Human senile cataractous lens protease. Isolation and some chemical characteristics | |
| Trikha et al. | Purification and characterization of fibrolase isoforms from venom of individual southern copperhead (Agkistrodon contortrix contortrix) snakes | |
| Smythe et al. | Rat liver uroporphyrinogen III synthase has similar properties to the enzyme from Euglena gracilis, including absence of a requirement for a reversibly bound cofactor for activity | |
| Takagi et al. | Purification and some properties of fibrin stabilizing factor | |
| Kamata et al. | Characterization of the complex between α2-macroglobulin and a serine proteinase from Bacillus natto | |
| Mogel et al. | Photomodification of a serine at the active site of ribulose-1, 5-bisphosphate carboxylase/oxygenase by vanadate | |
| Nakata et al. | Simple and rapid purification of tryptophan 5-monooxygenase from rabbit brain by affinity chromatography | |
| Carroll et al. | Identification of the trypsin-like activity in commercial preparations of eel acetylcholinesterase | |
| Oettgen et al. | Purification, preliminary characterization, and immunological comparison of hog lens leucine aminopeptidase (EC 3.4. 11.1) with hog kidney and beef lens aminopeptidases | |
| Gounaris et al. | Cathepsin B from human renal cortex | |
| Pal et al. | Dipeptidyl peptidase I from goat brain: purification, characterization and its action on Leu-enkephalin | |
| Mawal et al. | Purification and properties of kynurenine aminotransferase from rat kidney | |
| JPH0965879A (ja) | 新規血栓溶解酵素とその製造方法 | |
| Nagayama et al. | Mouse bone collagenase inhibitor: purification and partial characterization of the inhibitor from mouse calvaria cultures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19830630 |
|
| PG1501 | Laying open of application | ||
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 19860610 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 19860827 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 19860610 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |